Skip to main content
Premium Trial:

Request an Annual Quote

Michaela Ott, Michael Ott, Stephen Von Rump, David Patterson

Medite Cancer Diagnostics has accepted the resignation of Micheala and Michael Ott, who served as chief operating officer and managing director respectively. Both Otts will remain on the company's board of directors, however Michael Ott has stepped down as chairman of the board. The company also appointed Stephen Von Rump as chief commercialization and strategy officer and David Patterson as chairman of the company's board of directors.